BR9711513A - Uso de antagonistas de leptina para o tratamento de resistencia a insulina em diabete do tipo ii - Google Patents

Uso de antagonistas de leptina para o tratamento de resistencia a insulina em diabete do tipo ii

Info

Publication number
BR9711513A
BR9711513A BR9711513A BR9711513A BR9711513A BR 9711513 A BR9711513 A BR 9711513A BR 9711513 A BR9711513 A BR 9711513A BR 9711513 A BR9711513 A BR 9711513A BR 9711513 A BR9711513 A BR 9711513A
Authority
BR
Brazil
Prior art keywords
diabetes
treatment
type
insulin resistance
leptin antagonists
Prior art date
Application number
BR9711513A
Other languages
English (en)
Inventor
Guenter Mueller
Gerald Preibisch
Johann Ertl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9711513A publication Critical patent/BR9711513A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
BR9711513A 1996-09-20 1997-09-15 Uso de antagonistas de leptina para o tratamento de resistencia a insulina em diabete do tipo ii BR9711513A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19638487 1996-09-20
PCT/EP1997/005035 WO1998012224A1 (en) 1996-09-20 1997-09-15 Use of leptin antagonists for treating insulin resistance in type ii diabetes

Publications (1)

Publication Number Publication Date
BR9711513A true BR9711513A (pt) 1999-08-24

Family

ID=7806282

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711513A BR9711513A (pt) 1996-09-20 1997-09-15 Uso de antagonistas de leptina para o tratamento de resistencia a insulina em diabete do tipo ii

Country Status (18)

Country Link
US (1) US6399745B1 (pt)
EP (1) EP0956302A1 (pt)
JP (1) JP2001500869A (pt)
KR (1) KR20010029537A (pt)
CN (1) CN1230966A (pt)
AR (1) AR008444A1 (pt)
AU (1) AU735178B2 (pt)
BR (1) BR9711513A (pt)
CA (1) CA2266585A1 (pt)
CZ (1) CZ90999A3 (pt)
HU (1) HUP9904023A3 (pt)
ID (1) ID21861A (pt)
IL (1) IL129057A0 (pt)
NO (1) NO991186L (pt)
PL (1) PL332458A1 (pt)
RU (1) RU2201249C2 (pt)
WO (1) WO1998012224A1 (pt)
ZA (1) ZA978455B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756617B2 (en) 1998-07-28 2003-01-16 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Leptin-mediated gene-induction
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
AU782230B2 (en) 1999-09-22 2005-07-14 Serono Genetics Institute S.A. Methods of screening for compounds that modulate the LSR-leptin interaction and their use in the prevention and treatment of obesity-related diseases
EP1283878B1 (en) 2000-05-22 2005-07-27 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Receptor-based interaction trap
US7235629B2 (en) 2000-11-14 2007-06-26 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Functional fragment of the leptin receptor
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
CN103897066A (zh) 2004-02-11 2014-07-02 安米林药品有限责任公司 具有可选择特性的杂合多肽
US7407929B2 (en) * 2004-05-07 2008-08-05 Boston Biomedical Research Institute Leptin peptide antagonists
US7423113B2 (en) 2004-08-25 2008-09-09 Vib Vzw Leptin antagonist
KR101123549B1 (ko) 2004-11-01 2012-04-18 아밀린 파마슈티칼스, 인크. 비만 및 관련 장애의 치료
US8394765B2 (en) * 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
WO2006053883A1 (en) 2004-11-18 2006-05-26 Vib Vzw Fibronectin iii domain as leptin receptor antagonists
US7307142B2 (en) * 2004-11-26 2007-12-11 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Leptin antagonists
EP2392595A1 (en) 2005-02-11 2011-12-07 Amylin Pharmaceuticals Inc. GIP analog and hybrid polypeptides with selectable properties
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
BRPI0614649A2 (pt) 2005-08-11 2011-04-12 Amylin Pharmaceuticals Inc polipeptìdeos hìbridos com propriedades selecionáveis
EP1922336B1 (en) 2005-08-11 2012-11-21 Amylin Pharmaceuticals, LLC Hybrid polypeptides with selectable properties
EA200870365A1 (ru) * 2006-03-23 2009-02-27 Амилин Фармасьютикалз, Инк. Эндотелин и агонисты рецепторов к эндотелину в лечении заболеваний обмена веществ
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
US20100323955A1 (en) * 2007-11-14 2010-12-23 Amylin Pharmaceuticals, Inc. Methods for treating obesity and obesity related diseases and disorders
US8778890B2 (en) 2009-03-31 2014-07-15 Temple University—Of the Commonwealth System of Higher Education Leptin antagonist and methods of use
EP2416797A4 (en) 2009-04-10 2013-04-24 Amylin Pharmaceuticals Llc AMYLINAGONIST COMPOUNDS FOR OXYGEN ANIMAL MICE
CA3138758A1 (en) 2010-09-28 2012-04-19 Amylin Pharmaceuticals, Llc Highly soluble leptins
JP6040464B2 (ja) 2011-07-08 2016-12-07 アエゲリオン・ファーマシューティカルズ・インコーポレイテッドＡｅｇｅｒｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
RU2650646C2 (ru) 2012-09-27 2018-04-16 Дзе Чилдрен'З Медикал Сентер Корпорейшн Соединения, предназначенные для лечения ожирения, и способы их применения
HUE042196T2 (hu) 2013-11-26 2019-06-28 Childrens Medical Ct Corp Vegyületek elhízás kezelésére és alkalmazási eljárásaik
WO2015153933A1 (en) 2014-04-03 2015-10-08 The Children's Medical Center Corporation Hsp90 inhibitors for the treatment of obesity and methods of use thereof
CN104829707B (zh) * 2015-05-06 2017-12-19 广东省生物资源应用研究所 一条cd环和e螺旋区突变的瘦素活性肽及其编码基因和应用
CN104829708B (zh) 2015-05-06 2017-11-28 广东省生物资源应用研究所 一条d螺旋区突变的瘦素活性肽及其编码基因和应用
WO2017013270A1 (en) 2015-07-23 2017-01-26 Universite De Strasbourg Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy
EA201990720A1 (ru) 2016-09-12 2019-08-30 Эгерион Фармасьютикалс, Инк. Способы детекции нейтрализующих антител к лептину
EP3675961A1 (en) * 2017-08-31 2020-07-08 University Of Dundee Leptin peptides and their use for treating neurological disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6001968A (en) * 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US5563243A (en) * 1995-01-31 1996-10-08 Eli Lilly And Company Anti-obesity proteins
US5574133A (en) * 1995-01-31 1996-11-12 Eli Lilly And Company Anti-obesity proteins
US5521283A (en) * 1995-01-31 1996-05-28 Eli Lilly And Company Anti-obesity proteins
US5525705A (en) * 1995-01-31 1996-06-11 Eli Lilly And Company Anti-obesity proteins
US5569743A (en) * 1995-01-31 1996-10-29 Eli Lilly And Company Anti-obesity proteins
KR19990028388A (ko) * 1995-06-30 1999-04-15 피터 지. 스트링거 당뇨병 치료 방법
US7063958B1 (en) * 1996-01-16 2006-06-20 The Rockefeller University Nucleic acids db, the receptor for leptin
US5922678A (en) * 1996-06-28 1999-07-13 Eli Lilly And Company Methods for treating diabetes

Also Published As

Publication number Publication date
PL332458A1 (en) 1999-09-13
ZA978455B (en) 1998-03-20
NO991186D0 (no) 1999-03-11
WO1998012224A1 (en) 1998-03-26
ID21861A (id) 1999-08-05
IL129057A0 (en) 2000-02-17
HUP9904023A2 (hu) 2000-03-28
NO991186L (no) 1999-03-11
US6399745B1 (en) 2002-06-04
AR008444A1 (es) 2000-01-19
JP2001500869A (ja) 2001-01-23
CA2266585A1 (en) 1998-03-26
HUP9904023A3 (en) 2002-01-28
RU2201249C2 (ru) 2003-03-27
AU4458697A (en) 1998-04-14
EP0956302A1 (en) 1999-11-17
KR20010029537A (ko) 2001-04-06
CN1230966A (zh) 1999-10-06
AU735178B2 (en) 2001-07-05
CZ90999A3 (cs) 1999-06-16

Similar Documents

Publication Publication Date Title
BR9711513A (pt) Uso de antagonistas de leptina para o tratamento de resistencia a insulina em diabete do tipo ii
BR9506768A (pt) Seringa hipodérmica para uso único
DK0758255T3 (da) Sprøjte med lav modstand
BR9706968A (pt) Uso de antagonistas de alfa-ppar e gama-ppar para o tratamento de sindrome x
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
DK0833612T3 (da) Ny farmaceutisk sammensætning med bedøvende virkning
FI955235A0 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
ATE259349T1 (de) Neue aminosäurederivate mit verbesserter multidrogenresistenz-aktivität
BR9006158A (pt) Estrutura prendedosa do tipo aberto,para uso em partes giratorias
PT825861E (pt) Tripicolinato cromico em doses elevadas para o tratamento de diabetes de tipo ii
BR9401740A (pt) Agulha de resina reversível e descartável para uso intravenoso
FR2718358B1 (fr) Seringue à usage unique à aiguille rétractable.
IL133136A0 (en) Use of leptin antagonists for the treatment of diabetes
EE200000056A (et) 4-okso-3,5-dihüdro-4H-püridasino[4.5-b]indool-1-etaanamiidi derivaadid, nende valmistamine ja kasutamine raviks
EE9900218A (et) 1,4-diasabitsüklo[2.2.2]okt-2-üülmetüülbensoaadi derivaadid, nende valmistamine ja kasutamine raviks
NO20002346L (no) Ny formulering for bruk i smertebehandling
ES1032221Y (es) Tobogan componible perfeccionado para uso infantil.
DE29822149U1 (de) Homogenisator mit Schutzverzahnung
BR9701247A (pt) Composição para uso em medicina estética e aplicação da mesma
DE29721448U1 (de) Spritze mit Sicherheitsabdeckung
ES1038353Y (es) Jeringuilla perfeccionada.
ES1025589Y (es) Jeringuilla perfeccionada de un solo uso
ES1012288Y (es) Andador perfeccionado para uso ortopedico.
ES1019436Y (es) Jeringuilla perfeccionada de un solo uso.
ES1012927Y (es) Jeringa de un solo uso perfeccionada.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO, DE ACORDO COM ARTIGO 8O DA LPI